Stress Dosing of Steroid Third QPEM Conference 11-13 th of January - - PowerPoint PPT Presentation

stress dosing of steroid
SMART_READER_LITE
LIVE PREVIEW

Stress Dosing of Steroid Third QPEM Conference 11-13 th of January - - PowerPoint PPT Presentation

Stress Dosing of Steroid Third QPEM Conference 11-13 th of January 2019 Dr. Mahmoud Alrifaai Consultant pediatrics . PEC. Alsadd DISCLOSURE I do not have any relevant financial relationship with commercial interest to disclose. Learning


slide-1
SLIDE 1
  • Dr. Mahmoud Alrifaai

Consultant pediatrics . PEC. Alsadd

Third QPEM Conference 11-13th of January 2019

Stress Dosing of Steroid

slide-2
SLIDE 2

I do not have any relevant financial relationship with commercial interest to disclose.

DISCLOSURE

slide-3
SLIDE 3

Learning Objective

Assess the need for steroid stress dose in different situations.

slide-4
SLIDE 4

Examples

  • Case -1 : 12 years old male with CAH .

Acute vomiting, abdominal pain, temperature of 38.5, hypotensive .

slide-5
SLIDE 5

Examples

  • Case -1 : 12 years old male with CAH .

Acute vomiting, abdominal pain, temperature of 38.5, hypotensive .

  • Case -2 : 4 months old male with congenital hypopituitarism .

URTI and fever of 38.3C. , no vomiting , normal V.S . Usual medication hydrocortisone total is 5 mg/day.

slide-6
SLIDE 6

Examples

  • Case -1 : 12 years old male with CAH .

Acute vomiting, abdominal pain, temperature of 38.5, hypotensive .

  • Case -2 : 4 months old male with congenital hypopituitarism .

URTI and fever of 38.3C. , no vomiting , normal V.S . Usual medication hydrocortisone total is 5 mg/day.

  • Case -3 : 3 years old female with nephrotic syndrome ,
  • wt. 15 kg , on prednisolone 5mg every other day .

Loose motion and fever 39c ,no vomiting . Normal V.S .

slide-7
SLIDE 7

Introduction

Alamy Stock Photo Image ID: D9NTJ7

slide-8
SLIDE 8

Introduction

  • GLUCOCORTICOIDS (CORTISOL ):
  • Stress hormone secreted by adrenal cortex .It causes :

Ø Gluconeogenesis : Increase glucose level in blood . Ø Proteolysis : increase of amino acids in the blood. Ø Lipolysis : increase fatty acid in the blood. Ø Anti-inflammatory: reduce pain . Ø Immuno-suppressive Ø Maintains cardiovascular system as well as kidney function.

slide-9
SLIDE 9

123rf.com

slide-10
SLIDE 10

Patients at risk for adrenal crisis

slide-11
SLIDE 11

Suppressed (HPAA) by Exogenous glucocorticoids .

Oral glucocorticoid : § Maintenance daily dose 7-12 mg/m2

  • f hydrocortisone or equivalent .

§ Administration of higher daily dose for >4 wks. may suppress HPAA. § Alternative daily doses do not affect HPAA. Inhaled glucocorticoid : High doses fluticasone >800mcg/day >4 wks. need HPAA evaluation Local application : Reported cases of Cushing syndrome and adrenal insufficiency after of high potency topical corticosteroids (clopitasole ).

slide-12
SLIDE 12

Management principles

Ø ABC,D , bed side RBS , electrolytes …

Ø Hydrocortisone steroid of choice as a stress dose , why ? 1- Short acting 6-8 hrs. duration 2- Reach therapeutic level after 10-20 min of IV/IM inj. 3- Mineralocorticoid effect ,Hydrocortisone 20 mg = 0.1 mg fludrocortisone. v Dexamethasone not recommended (mineralcorticoid effect =0) Ø All children at risk of adrenal insufficiency should be discussed with/and admitted under the Pediatric Endocrinology Team . Ø Treat underling cause

slide-13
SLIDE 13

Patient’s condition Hydrocortisone Severely ill +/- shock

75-100 mg/m2 bolus + followed by cont. infusion vs. divided doses 50-100 mg/m2/day until stable

Moderately ill

50 mg/m2/day PO. or give 5x (times) the daily dose;

  • r 50 mg/m2/day IV/IM, divided 6 hourly

Mildly ill ( URTI) , no fever

  • Cont. normal maintenance doses of steroid.

Brief surgery

50 mg/m2 PO. at the onset of ‘NPO’ , or same dose IV prior to anesthesia

Prolonged surgery

50 mg/m2 bolus IV followed by 50 - 100 mg/m2/day divided doses or cont. infusion. The following days 3- 4 times the patient's usual dose.

slide-14
SLIDE 14

Rapid Estimates of steroid dose if Weight or BSA not available Age Hydrocortisone stress dose

IV/IM

0-3 years 25 mg 3-12 years 50 mg ≥ 12 years 100 mg

slide-15
SLIDE 15

In the management Septic shock in previously healthy child IS stress steroid dose recommended ??

Ø Glucocorticoids should not be routinely used in septic shock .

  • Their use was associated with increased mortality.

Ø Refractory catecholamine resistant septic shock :

stress steroid dose is recommended .

  • Adrenal insufficiency occurs in many conditions in critically ill

children .

slide-16
SLIDE 16

Examples

  • Case -1 : 12 year ,CAH, febrile, and hypotensive .
  • 100 mg hydrocortisone IM/IV followed by a cont.

infusion of 100 mg/m2/day until clinically stable.

  • Case -2 : 4 month ,congenital hypopituitarism URTI & febrile .

Usual daily hydrocortisone dose 5 mg/day.

  • 25 mg hydrocortisone /day PO. until fever resolves.
  • Case -3 : 3 years ,nephrotic synd. on prednisolone 5mg every
  • ther day + GE.
  • Continue same dose of prednisolone unless patient in relapse .
slide-17
SLIDE 17

Take home messages

All children at risk of adrenal insufficiency should be discussed with/and admitted under the Pediatric Endocrinology Team. Increased Cortisol is needed in times of stress to avoid adrenal crisis. Hydrocortisone is the steroid of choice as stress dose . Dexamethasone not recommended. Steroids not routinely recommended in septic shock in previously healthy child.

slide-18
SLIDE 18

References

  • Markovitz BP

, Goodman DM, Watson RS, et al. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care Med 2005; 6:270

  • Brandon DD, Isabelle LM, Samuels MH, et al. Cortisol production rate measurement by stable isotope dilution using gas

chromatography-negative ion chemical ionization mass spectrometry. Steroids 1999; 64:372.

  • Linder BL, Esteban NV, Yergey AL, et al. Cortisol production rate in childhood and adolescence. J Pediatr 1990; 117:892.
  • Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital

adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 2001; 169:65.

  • Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society

Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101:364

  • Uptodate
slide-19
SLIDE 19

Thank you